Bohai Pharmaceuticals Group (BOPH) Return on Assets ROA from the first quarter of 2015 to first quarter of 2014 and for the year 2015, Average High and Low, Fundamental Ratios from Sep 30 2014 to Sep 30 2013 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bohai Pharmaceuticals Group, Inc.  (BOPH)


Bohai Pharmaceuticals Group's ROA from the first quarter of 2015 to the first quarter of 2014 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Bohai Pharmaceuticals Group's ROA in the first quarter of 2015?
Bohai Pharmaceuticals Group, Inc. achieved a return on average assets (ROA) of 12.56 % in its first quarter of 2015, which is below Bohai Pharmaceuticals Group's average return on assets, which stands at 12.57%.

ROA has improved compared to 12.33% in the fourth quarter of 2014, due to net income growth.

However, within the Healthcare sector 101 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2014 from 699 to 746.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Total Assets Change 15.25 % 11.56 % 11.78 % 9 % 17.7 %
Y / Y Net Income Change 15.53 % -10.34 % 24.34 % 14.27 % 26.46 %
Net Income (TTM) in million 23 22 22 22 21
Return On Assets (TTM) 12.56 % 12.33 % 12.93 % 12.83 % 12.65 %
BOPH's Total Ranking # 746 # 699 # 739 # 572 # 576
Total Assets (TTM) in million 204 185 176 173 177
Seq. Total Assets Change 10.23 % 5.16 % 1.55 % -2.08 % 6.69 %
Seq. Net Income Change 141.8 % -1.62 % -34.63 % -25.7 % 87.65 %

BOPH's 5 Years Annual ROA >> Back to BOPH Management Effectiveness >> Compare BOPH ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 17
Sector # 102
Overall # 568

Return On Assets Statistics
High Average Low
12.93 %
12.57 %
12.11 %
(Mar 31 2014)   (Jun 30 2013)





Financial Statements
Bohai Pharmaceuticals Group's Assets $ 204 million BOPH's Balance sheet
Bohai Pharmaceuticals Group's Income $ 9 million Quarterly BOPH's Income Statement
BOPH's Income by Division See BOPH's Income by Division



Annual Return On Assets (Jun 30 2014)
FY 2014		 (Jun 30 2013)
FY 2013		 (Jun 30 2012)
FY 2012
FY
FY
Y / Y Total Assets Change 11.56 % 13.91 % - - -
Total Assets in million 185 166 145 0 0
Y / Y Net Income Change 14.46 % 98.21 % - - -
Net Income in million 22 19 10 0 0
Annual Return On Assets 11.85 % 11.55 % 6.64 % - -

BOPH's 5 Years Annual ROA >> Back to BOPH Management Effectiveness >> Compare BOPH ROA to its Competitors



Comment on BOPH's ROA in the fiscal year ending 2014
In the fiscal year 2014 ROA improved to 11.85 % compared to prior year, due to annual net income growth of 14.46 % to $21.89 million, while value of Bohai Pharmaceuticals Group's overall assets grew just by 11.56 % to $184.77 million, compared to $184.77 a year before.


More Return On Assets Ratios
BOPH's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BOPH's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BOPH's Competitors
Subscribers only: Roa for Bohai Pharmaceuticals Group's Suppliers
Subscribers only: Return On Assets for BOPH's Customers

You may also want to know
BOPH's Roi BOPH's Inventory Turnover Ratio BOPH's Growth Rates BOPH's Dividend Comparisons
BOPH's Profitability Ratios BOPH's Asset Turnover Ratio BOPH's Dividend Growth
BOPH's Roe BOPH's Valuation Ratios BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2014, within Healthcare Sector ROA
Gilead Sciences Inc   33.93 %
Sonoma Pharmaceuticals Inc   33.83 %
Iveric Bio Inc   33.75 %
Tenax Therapeutics Inc   32.18 %
Positron Corporation  30.78 %
Applied Genetic Technologies Corporation  30.68 %
Agios Pharmaceuticals Inc   30.34 %
Lannett Company Inc  30.28 %
Mirati Therapeutics Inc   29.81 %
Oramed Pharmaceuticals Inc  29.72 %
Vbi Vaccines Inc  28.41 %
Portola Pharmaceuticals inc   28.02 %
Cv Sciences Inc   27.52 %
Bioage Labs Inc   26.98 %
Edwards Lifesciences Corporation  25.81 %
Enanta Pharmaceuticals Inc  25.50 %
Insys Therapeutics, Inc.  25.41 %
Lifevantage Corp  21.72 %
Anika Therapeutics Inc   21.40 %
China Biologic Products Holdings Inc   21.39 %
Ani Pharmaceuticals Inc  20.35 %
Biogen Inc   19.79 %
Meridian Bioscience Inc   19.61 %
Luna Innovations Inc  19.51 %
Nutrastar International Inc.  18.14 %
Biospecifics Technologies Corp  17.81 %
Fonar Corporation  17.43 %
Psychemedics Corporation  16.84 %
Myriad Genetics Inc   16.81 %
Bausch Health Companies Inc   16.67 %

Date modified: 2026-09-12T06:21:53+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.